Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A pill that works by putting the hunger induced by cannabis into reverse could jump-start a languishing market for obesity drugs, reports Meredith Wadman.
Big pharmaceutical companies are moving swiftly to acquire biotechnology companies — especially if they can snap them up on the cheap. Meredith Wadman reports.
A share offering beckons this autumn for QinetiQ, a business that is being built out of some of Britain's most famous military research laboratories. Andrea Chipman reports.